Kazumasa Yokoyama

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Differences of Behavioral and Psychological Symptoms of Dementia in Disease Severity in Four Major Dementias

Hiroaki Kazui, Kenji Yoshiyama, Hideki Kanemoto et al. · PLoS ONE · 2016 · 149 citations · Full text

Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis

Jun‐ichi Satoh, Megumi Nakanishi, Fumiko Koike et al. · Neurobiology of Disease · 2005 · 131 citations · Full text

Autoimmune Disease, Microarray Analysis Identifies, Medicine +11

Synthetic MRI in the Detection of Multiple Sclerosis Plaques

Akifumi Hagiwara, Masaaki Hori, Kazumasa Yokoyama et al. · American Journal of Neuroradiology · 2016 · 104 citations · Full text

p250GAP, a Novel Brain-enriched GTPase-activating Protein for Rho Family GTPases, Is Involved in the<i>N</i>-Methyl-<scp>d</scp>-aspartate Receptor Signaling

Takanobu Nakazawa, Ayako M. Watabe, Tohru Tezuka et al. · Molecular Biology of the Cell · 2003 · 99 citations · Full text

Synaptic Transmission, Structural Plasticity, Synaptic Signaling +20